Vericel
VCEL · NASDAQ
Bulios Fair Price
$31.73
20.7% downside
Current Price
$40.02
According to Bulios Fair Price, VCEL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Vericel Corporation is a biotechnology company that specializes in the development and commercialization of advanced therapies for tissue regeneration. The company primarily focuses on treating severe wounds, burns, and orthopedic conditions, offering autologous cell therapies that use a patient’s own cells to support healing and regeneration. Its key products include Epicel, a therapy for burn treatment, and Carticel, a cell therapy for cartilage repair.
Sector
Healthcare
Industry
Biotechnology
CEO
Dominick C. Colangelo
Employees
398
Headquarters
Burlington
Upcoming events
Earnings
Upcoming earnings report